• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
UCM
Click for more information
0.00% 3.2¢

USCOM LIMITED - Announcements

Market Cap $3.506M  ! watchlist Created with Sketch. Add to my watchlist

Uscom Limited is a medical technology company. It specializes in the development and... Uscom Limited is a medical technology company. It specializes in the development and marketing of non-invasive cardiovascular and pulmonary medical devices. It has three suites of devices in the field of cardiac, vascular, and pulmonary monitoring: the USCOM 1A advanced haemodynamic monitor, Uscom BP+ central blood pressure monitor, and the Uscom SpiroSonic digital ultrasonic spirometers. The USCOM 1A is a non-invasive advanced haemodynamic monitor that measures cardiovascular function, detects irregularities, and is used to guide treatment. The USCOM 1A device has applications in emergency, intensive care medicine and anesthesia. The Uscom BP+ is a supra-systolic oscillometric central blood pressure monitor which measures blood pressure and blood pressure waveforms in the heart, as well as in the arm, information only previously available using invasive cardiac catheterization. Its VENTITEST digital ultrasonic ventilator testing solution is a new system for testing ventilators.More

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
UCM Uscom ends 2016 with record manufacturingPRICE SENSITIVE03/01/17
UCM Appendix 3B28/12/16
UCM Results of Meeting30/11/16
UCM Uscom 2016 AGM Presentation30/11/16
UCM ASX Listing Rule Waiver29/11/16
UCM Uscom Awarded Euro Grant for Lung Cancer DiagnosticPRICE SENSITIVE28/11/16
UCM Appendix 4G14/11/16
UCM Uscom CEO Appointed to Govt China Initiative07/11/16
UCM CE Mark for New Uscom Asthma and COPD Devices-UCM.AX PRICE SENSITIVE31/10/16
UCM Appendix 4C - quarterly-UCM.AX PRICE SENSITIVE28/10/16
UCM Notice of Annual General Meeting/Proxy Form-UCM.AX 28/10/16
UCM Paediatric Sepsis Outcomes Improved With USCOM-UCM.AX PRICE SENSITIVE26/10/16
UCM Uscom AGM Scheduled to 30th November-UCM.AX 13/10/16
UCM Uscom Budapest Revenue up 48%-UCM.AX PRICE SENSITIVE10/10/16
UCM Investors Presentation October 2016-UCM.AX 06/10/16
UCM Uscom Meets with Chinese Health Minister-UCM.AX PRICE SENSITIVE09/09/16
UCM 2016 Annual Results Investors Presentation-UCM.AX 29/08/16
UCM Change in substantial holding-UCM.AX 22/08/16
UCM Change of Director's Interest Notice-UCM.AX 18/08/16
UCM Appendix 3B-UCM.AX 18/08/16
UCM Preliminary and Annual Report to shareholders-UCM.AX PRICE SENSITIVE17/08/16
UCM Appendix 4C - quarterly-UCM.AX PRICE SENSITIVE21/07/16
UCM Additional Uscom BP Plus US Patent-UCM.AX PRICE SENSITIVE18/07/16
UCM New US Uscom BP Plus Patent-UCM.AX PRICE SENSITIVE11/07/16
UCM Investors Presentation - Global Growth-UCM.AX 21/06/16
UCM Uscom agreement with CIIC Shanghai-UCM.AX PRICE SENSITIVE16/06/16
UCM Cleansing Notice-UCM.AX 14/06/16
UCM Appendix 3B-UCM.AX 14/06/16
UCM New Uscom BP Plus Distributor in Vietnam-UCM.AX PRICE SENSITIVE14/06/16
UCM Oversubscribed PP for Strategic Investment-UCM.AX PRICE SENSITIVE08/06/16
UCM Investors Presentation June 2016-UCM.AX 02/06/16
UCM Uscom appoints new Company Secretary-UCM.AX 24/05/16
UCM Uscom Investors Presentation May 2016-UCM.AX 09/05/16
UCM Uscom may improve outcomes and reduce cost in surgery-UCM.AX PRICE SENSITIVE03/05/16
UCM Appendix 4C - quarterly-UCM.AX PRICE SENSITIVE12/04/16
UCM Paediatric sepsis mortality reduced 46% with USCOM usePRICE SENSITIVE31/03/16
UCM Appendix 3B23/03/16
UCM Initial Directors Interest Notice23/03/16
UCM Former J&J Asia Executive Appointed to Uscom Board23/03/16
UCM Investors presentation March 201617/03/16
UCM Uscom BP plus Contracted Into UK NHS Supply ChainPRICE SENSITIVE14/03/16
UCM Half Yearly Report and AccountsPRICE SENSITIVE23/02/16
UCM Appendix 4C - quarterlyPRICE SENSITIVE01/02/16
UCM Uscom BP Plus equal to catheters for Central BP in childrenPRICE SENSITIVE19/01/16
UCM Uscom New SpiroSonic Series of Asthma ProductsPRICE SENSITIVE25/11/15
UCM Results of Meeting24/11/15
UCM Uscom 2015 AGM Presentation24/11/15
UCM Uscom US CPT Code and Reimbursement UpdatePRICE SENSITIVE20/11/15
UCM Investor Presentation November 201519/11/15
UCM Uscom CEO Interviewed by Alan Kohler16/11/15
UCM USCOM can replace cardiac catheters in childrenPRICE SENSITIVE09/11/15
UCM Uscom Establishes UK SubsidiaryPRICE SENSITIVE04/11/15
UCM Appendix 3B27/10/15
UCM Appendix 4C - quarterlyPRICE SENSITIVE26/10/15
UCM Notice of Annual General Meeting/Proxy Form23/10/15
UCM Investor Presentation New York21/10/15
UCM Investor Presentation October 201502/10/15
UCM Appendix 3B01/10/15
UCM Change of Director's Interest Notice01/10/15
UCM 55% of all China mortality from cardiorespiratory diseasePRICE SENSITIVE17/09/15
UCM Investor Presentation04/09/15
UCM Investor Update01/09/15
UCM Uscom Completes Thor AcquisitionPRICE SENSITIVE01/09/15
UCM Change in substantial holding27/08/15
UCM Change of Director's Interest Notice26/08/15
UCM Change of Director's Interest Notice26/08/15
UCM Preliminary and Annual Report to shareholdersPRICE SENSITIVE26/08/15
UCM Appendix 4G26/08/15
UCM Appendix 3B21/08/15
UCM Uscom Limited - Cleansing Notice21/08/15
UCM Uscom Limited - Completion of Share Purchase Plan21/08/15
UCM Uscom Limited - Appendix 3B14/08/15
UCM Uscom Limited - Issue of Shares - Cleansing Notice14/08/15
UCM Appendix 3B31/07/15
UCM Uscom Limited - Cleansing Notice31/07/15
UCM USA FDA clearance for Thor ultrasonic spirometersPRICE SENSITIVE29/07/15
UCM Uscom Limited - Share Purchase Plan Document27/07/15
UCM Uscom Limited Share Purchase Plan - Cleansing Statement27/07/15
UCM Appendix 4C - quarterlyPRICE SENSITIVE27/07/15
UCM Uscom Limited - Securities issued under Listing Rule 7.1A23/07/15
UCM Appendix 3B23/07/15
UCM Uscom Limited - Placement - Cleansing Statement23/07/15
UCM Uscom - Investor Presentation - Global Momentum20/07/15
UCM Reinstatement to Official QuotationPRICE SENSITIVE20/07/15
UCM Uscom - Capital Raise & Acquisition of Thor LaboratoriesPRICE SENSITIVE20/07/15
UCM Suspension from Official QuotationPRICE SENSITIVE17/07/15
UCM Trading HaltPRICE SENSITIVE15/07/15
UCM USCOM signs eight new distribution agreementsPRICE SENSITIVE07/07/15
UCM Former Welch Allyn Executive appointed to Uscom USA06/07/15
UCM Investor Presentation June 201526/06/15
UCM Release of Securities from Voluntary Escrow18/06/15
UCM Uscom Limited - Updated Securities Trading Policy27/05/15
UCM USCOM Recognised by China National ICU SocietyPRICE SENSITIVE20/05/15
UCM Change of registry address15/05/15
UCM Receiving Research and Development Tax Incentive PaymentPRICE SENSITIVE30/04/15
UCM Appendix 4C - quarterlyPRICE SENSITIVE27/04/15
UCM New Research - USCOM for Hypertension Screening in PregnancyPRICE SENSITIVE21/04/15
UCM AMA Accepts CPT Code for Central Pressure Waveform MeasuresPRICE SENSITIVE31/03/15
UCM FY2015 Half Yearly Results Presentation26/02/15
UCM Half Yearly Report and AccountsPRICE SENSITIVE24/02/15
UCM Uscom ends 2016 with record manufacturing
03/01/17PRICE SENSITIVE
UCM Appendix 3B
28/12/16
UCM Results of Meeting
30/11/16
UCM Uscom 2016 AGM Presentation
30/11/16
UCM ASX Listing Rule Waiver
29/11/16
UCM Uscom Awarded Euro Grant for Lung Cancer Diagnostic
28/11/16PRICE SENSITIVE
UCM Appendix 4G
14/11/16
UCM Uscom CEO Appointed to Govt China Initiative
07/11/16
UCM CE Mark for New Uscom Asthma and COPD Devices-UCM.AX
31/10/16PRICE SENSITIVE
UCM Appendix 4C - quarterly-UCM.AX
28/10/16PRICE SENSITIVE
UCM Notice of Annual General Meeting/Proxy Form-UCM.AX
28/10/16
UCM Paediatric Sepsis Outcomes Improved With USCOM-UCM.AX
26/10/16PRICE SENSITIVE
UCM Uscom AGM Scheduled to 30th November-UCM.AX
13/10/16
UCM Uscom Budapest Revenue up 48%-UCM.AX
10/10/16PRICE SENSITIVE
UCM Investors Presentation October 2016-UCM.AX
06/10/16
UCM Uscom Meets with Chinese Health Minister-UCM.AX
09/09/16PRICE SENSITIVE
UCM 2016 Annual Results Investors Presentation-UCM.AX
29/08/16
UCM Change in substantial holding-UCM.AX
22/08/16
UCM Change of Director's Interest Notice-UCM.AX
18/08/16
UCM Appendix 3B-UCM.AX
18/08/16
UCM Preliminary and Annual Report to shareholders-UCM.AX
17/08/16PRICE SENSITIVE
UCM Appendix 4C - quarterly-UCM.AX
21/07/16PRICE SENSITIVE
UCM Additional Uscom BP Plus US Patent-UCM.AX
18/07/16PRICE SENSITIVE
UCM New US Uscom BP Plus Patent-UCM.AX
11/07/16PRICE SENSITIVE
UCM Investors Presentation - Global Growth-UCM.AX
21/06/16
UCM Uscom agreement with CIIC Shanghai-UCM.AX
16/06/16PRICE SENSITIVE
UCM Cleansing Notice-UCM.AX
14/06/16
UCM Appendix 3B-UCM.AX
14/06/16
UCM New Uscom BP Plus Distributor in Vietnam-UCM.AX
14/06/16PRICE SENSITIVE
UCM Oversubscribed PP for Strategic Investment-UCM.AX
08/06/16PRICE SENSITIVE
UCM Investors Presentation June 2016-UCM.AX
02/06/16
UCM Uscom appoints new Company Secretary-UCM.AX
24/05/16
UCM Uscom Investors Presentation May 2016-UCM.AX
09/05/16
UCM Uscom may improve outcomes and reduce cost in surgery-UCM.AX
03/05/16PRICE SENSITIVE
UCM Appendix 4C - quarterly-UCM.AX
12/04/16PRICE SENSITIVE
UCM Paediatric sepsis mortality reduced 46% with USCOM use
31/03/16PRICE SENSITIVE
UCM Appendix 3B
23/03/16
UCM Initial Directors Interest Notice
23/03/16
UCM Former J&J Asia Executive Appointed to Uscom Board
23/03/16
UCM Investors presentation March 2016
17/03/16
UCM Uscom BP plus Contracted Into UK NHS Supply Chain
14/03/16PRICE SENSITIVE
UCM Half Yearly Report and Accounts
23/02/16PRICE SENSITIVE
UCM Appendix 4C - quarterly
01/02/16PRICE SENSITIVE
UCM Uscom BP Plus equal to catheters for Central BP in children
19/01/16PRICE SENSITIVE
UCM Uscom New SpiroSonic Series of Asthma Products
25/11/15PRICE SENSITIVE
UCM Results of Meeting
24/11/15
UCM Uscom 2015 AGM Presentation
24/11/15
UCM Uscom US CPT Code and Reimbursement Update
20/11/15PRICE SENSITIVE
UCM Investor Presentation November 2015
19/11/15
UCM Uscom CEO Interviewed by Alan Kohler
16/11/15
UCM USCOM can replace cardiac catheters in children
09/11/15PRICE SENSITIVE
UCM Uscom Establishes UK Subsidiary
04/11/15PRICE SENSITIVE
UCM Appendix 3B
27/10/15
UCM Appendix 4C - quarterly
26/10/15PRICE SENSITIVE
UCM Notice of Annual General Meeting/Proxy Form
23/10/15
UCM Investor Presentation New York
21/10/15
UCM Investor Presentation October 2015
02/10/15
UCM Appendix 3B
01/10/15
UCM Change of Director's Interest Notice
01/10/15
UCM 55% of all China mortality from cardiorespiratory disease
17/09/15PRICE SENSITIVE
UCM Investor Presentation
04/09/15
UCM Investor Update
01/09/15
UCM Uscom Completes Thor Acquisition
01/09/15PRICE SENSITIVE
UCM Change in substantial holding
27/08/15
UCM Change of Director's Interest Notice
26/08/15
UCM Change of Director's Interest Notice
26/08/15
UCM Preliminary and Annual Report to shareholders
26/08/15PRICE SENSITIVE
UCM Appendix 4G
26/08/15
UCM Appendix 3B
21/08/15
UCM Uscom Limited - Cleansing Notice
21/08/15
UCM Uscom Limited - Completion of Share Purchase Plan
21/08/15
UCM Uscom Limited - Appendix 3B
14/08/15
UCM Uscom Limited - Issue of Shares - Cleansing Notice
14/08/15
UCM Appendix 3B
31/07/15
UCM Uscom Limited - Cleansing Notice
31/07/15
UCM USA FDA clearance for Thor ultrasonic spirometers
29/07/15PRICE SENSITIVE
UCM Uscom Limited - Share Purchase Plan Document
27/07/15
UCM Uscom Limited Share Purchase Plan - Cleansing Statement
27/07/15
UCM Appendix 4C - quarterly
27/07/15PRICE SENSITIVE
UCM Uscom Limited - Securities issued under Listing Rule 7.1A
23/07/15
UCM Appendix 3B
23/07/15
UCM Uscom Limited - Placement - Cleansing Statement
23/07/15
UCM Uscom - Investor Presentation - Global Momentum
20/07/15
UCM Reinstatement to Official Quotation
20/07/15PRICE SENSITIVE
UCM Uscom - Capital Raise & Acquisition of Thor Laboratories
20/07/15PRICE SENSITIVE
UCM Suspension from Official Quotation
17/07/15PRICE SENSITIVE
UCM Trading Halt
15/07/15PRICE SENSITIVE
UCM USCOM signs eight new distribution agreements
07/07/15PRICE SENSITIVE
UCM Former Welch Allyn Executive appointed to Uscom USA
06/07/15
UCM Investor Presentation June 2015
26/06/15
UCM Release of Securities from Voluntary Escrow
18/06/15
UCM Uscom Limited - Updated Securities Trading Policy
27/05/15
UCM USCOM Recognised by China National ICU Society
20/05/15PRICE SENSITIVE
UCM Change of registry address
15/05/15
UCM Receiving Research and Development Tax Incentive Payment
30/04/15PRICE SENSITIVE
UCM Appendix 4C - quarterly
27/04/15PRICE SENSITIVE
UCM New Research - USCOM for Hypertension Screening in Pregnancy
21/04/15PRICE SENSITIVE
UCM AMA Accepts CPT Code for Central Pressure Waveform Measures
31/03/15PRICE SENSITIVE
UCM FY2015 Half Yearly Results Presentation
26/02/15
UCM Half Yearly Report and Accounts
24/02/15PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
3.2¢ 		Change
0.000(0.00%) 		Mkt cap ! $3.506M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 150000 1.7¢
 

Sellers (Offers)

Price($) Vol. No.
3.2¢ 200000 1
View Market Depth
Last trade - 16.12pm 29/11/2024 (20 minute delay) ?
UCM (ASX) Chart

Top Stories

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

The ASX200 has been really flirting with the 8,500pts mark this week, notching an intraweek ATH of 8,476pts.
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
HotCopper Highlights: Your most watched stocks for Week 48, 2024 Good afternoon, a happy end of the week, and welcome to HotCopper Highlights – I’m Jonathon Davidson. Let’s get into it.
Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher Vitrafy Life Sciences Limited (ASX:VFY) has defied this month’s odds to become the only newly-listed Australian company to survive a surprisingly rough November (for newcomers, at least) without sagging below its IPO price.The cryopreservation biotech did give some back on Friday,...
Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia New Zealand’s Reserve Bank has taken a bold step, slashing rates by 50 basis points to 4.25% @ its third cut in just four months. Meanwhile, the Reserve Bank of Australia holds firm at 4.35%, its highest rate in over a decade.This stark policy divergence highlights contrasting glo...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.